AMSTERDAM · EST. 2026
Onpeps
PEPTIDE DECISION INTELLIGENCE
Subscribe
← PEPTIDE LIBRARY
COGNITIVEGRADE DSPECULATIVE / THIN

Selank

Anxiolytic heptapeptide (tuftsin analog)

A synthetic analog of the immunomodulatory peptide tuftsin, developed in Russia as an anxiolytic. Most of the published work originates from Russian research groups.

ALSO KNOWN AS TP-7
REGULATORY STATUS · RESEARCH COMPOUND

Research compound; registered as a drug in Russia, not FDA-approved. Compounds in this category have not been approved for human use; availability is typically restricted to laboratory research.

§ EVIDENCE BASE
68
PUBLICATIONS
indexed in PubMed
2
REGISTERED TRIALS
listing it as an intervention
0
PHASE 2–4 TRIALS
reached later-stage testing
MECHANISMAnxiolytic heptapeptide (tuftsin analog)
CATEGORYCognitive
EVIDENCE GRADED — Speculative / thin
STATUSResearch compound; registered as a drug in Russia, not FDA-approved
COUNTS RETRIEVED2026-07-23 · re-run the PubMed query
§ RELATED COMPOUNDS
COGNITIVED
Semax
ACTH(4-10) analog; BDNF modulation
NOT MEDICAL ADVICE

This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.

THE WEEKLY BRIEF

Peptide intelligence, every Monday.

One concise email: the newest research, evidence updates, and quality signals — no hype, no spam.

Onpeps

Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.

EXPLORE
FOLLOW
PEPTIDE INFORMATION YOU CAN VERIFY© 2026 ONPEPS · AMSTERDAM, NETHERLANDS · NOT MEDICAL ADVICE